Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.

Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.

<h4>Purpose</h4>Percutaneous hepatic perfusion with melphalan (M-PHP) is increasingly used in patients with liver metastases from various primary tumors, yet data on colorectal liver metastases (CRLM) are limited. The aim of this study was to prospectively evaluate the efficacy and safet...

Full description

Bibliographic Details
Main Authors: T Susanna Meijer, Jan H N Dieters, Eleonora M de Leede, Lioe-Fee de Geus-Oei, Jaap Vuijk, Christian H Martini, Arian R van Erkel, Jacob Lutjeboer, Rutger W van der Meer, Fred G J Tijl, Ellen Kapiteijn, Alexander L Vahrmeijer, Mark C Burgmans
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0261939

Internet

https://doi.org/10.1371/journal.pone.0261939

Similar Items